ArticleBritish journal of clinical pharmacology2006

Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms.

Annika Bernsdorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.